We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Helios Technologies
HLIO
$2.24B
| $1.87K | ﹤0.01% |
+56
| New | +$1.69K |
2025 Q2
0 quarters
|
|
3027
PTC Therapeutics
PTCT
$5.09B
| $1.86K | ﹤0.01% |
38
| – | – |
2024 Q2
4 quarters
|
|
3028
Schrodinger
SDGR
$1.91B
| $1.85K | ﹤0.01% |
92
-19
| -17% | -$434 |
2023 Q3
7 quarters
|
|
3029
DELISTED
Olaplex Holdings
OLPX
| $1.85K | ﹤0.01% |
1,320
-4,981
| -79% | -$6.49K |
2022 Q2
12 quarters
|
|
3030
The RMR Group
RMR
$319M
| $1.85K | ﹤0.01% |
113
| – | – |
2016 Q4
34 quarters
|
|
3031
Global X Cloud Computing ETF
CLOU
$402M
| $1.84K | ﹤0.01% |
79
| – | – |
2020 Q2
20 quarters
|
|
3032
Grifois
GRFS
$5.13B
| $1.83K | ﹤0.01% |
202
-815
| -80% | -$6.37K |
2019 Q1
25 quarters
|
|
3033
TeraWulf
WULF
$6.3B
| $1.82K | ﹤0.01% |
416
+331
| +389% | +$1.13K |
2024 Q3
3 quarters
|
|
3034
YieldMax COIN Option Income Strategy ETF
CONY
$378M
| $1.8K | ﹤0.01% |
20
+10
| +100% | +$803 |
2024 Q4
2 quarters
|
|
3035
Sezzle
SEZL
$4.47B
| $1.79K | ﹤0.01% |
10
-6
| -38% | -$531 |
2024 Q4
2 quarters
|
|
3036
ArriVent BioPharma
AVBP
$828M
| $1.78K | ﹤0.01% |
+82
| New | +$1.7K |
2025 Q2
0 quarters
|
|
3037
Phathom Pharmaceuticals
PHAT
$607M
| $1.78K | ﹤0.01% |
186
-143
| -43% | -$791 |
2025 Q1
1 quarter
|
|
3038
DELISTED
Brookline Bancorp
BRKL
| $1.78K | ﹤0.01% |
169
| – | – |
2024 Q4
2 quarters
|
|
3039
Revolution Medicines
RVMD
$40.6B
| $1.77K | ﹤0.01% |
48
-463
| -91% | -$17.8K |
2024 Q2
4 quarters
|
|
3040
Millicom
TIGO
$13.8B
| $1.76K | ﹤0.01% |
47
| – | – |
2024 Q3
3 quarters
|
|
3041
Champion Homes
SKY
$4.34B
| $1.75K | ﹤0.01% |
28
-9
| -24% | -$700 |
2023 Q1
9 quarters
|
|
3042
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $1.75K | ﹤0.01% |
70
-300
| -81% | -$7.43K |
2024 Q4
2 quarters
|
|
3043
Mission Produce
AVO
$1.06B
| $1.74K | ﹤0.01% |
148
-355
| -71% | -$3.85K |
2025 Q1
1 quarter
|
|
3044
LCI Industries
LCII
$2.04B
| $1.73K | ﹤0.01% |
19
-9
| -32% | -$767 |
2021 Q1
17 quarters
|
|
3045
Adeia
ADEA
$2.4B
| $1.73K | ﹤0.01% |
122
| – | – |
2017 Q2
32 quarters
|
|
3046
Artesian Resources
ARTNA
$342M
| $1.71K | ﹤0.01% |
+51
| New | +$1.73K |
2025 Q2
0 quarters
|
|
3047
Taboola.com
TBLA
$956M
| $1.7K | ﹤0.01% |
463
-753
| -62% | -$2.46K |
2025 Q1
1 quarter
|
|
3048
Madison Square Garden
MSGE
$3.77B
| $1.68K | ﹤0.01% |
42
+11
| +35% | +$389 |
2025 Q1
1 quarter
|
|
3049
Kanzhun
BZ
$7.17B
| $1.68K | ﹤0.01% |
94
-54
| -36% | -$907 |
2025 Q1
1 quarter
|
|
3050
JetBlue
JBLU
$1.19B
| $1.67K | ﹤0.01% |
395
-1,568
| -80% | -$7.02K |
2016 Q4
34 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.